Ad
related to: what is bellatrix exploration ltd (bxe-t) 2A Combination Therapy That Can Be Administered For Adults with Advanced CRC. Ask Your Doctor About This Chemo-Free FDA-Approved Combination Therapy Treatment.
Search results
Jun 3, 2024 · What's going on at Bellatrix Exploration (TSE:BXE)? Read today's BXE news from trusted media outlets at MarketBeat.
- 345 N Reid Place, Suite 620, Sioux Falls, 57103, SD
- contact@marketbeat.com
- (844) 978-6257
1 day ago · Bellatrix Exploration Ltd., an oil and gas company, engages in the acquisition, exploration, development, and production of oil and natural gas reserves in west central Alberta, British Columbia, and Saskatchewan in Canada.
- 800-5th Avenue SW Suite 1920, CALGARY A0, T2P 3T6
- investor.relations@bxe.com
- (844) 978-6257
- 144
Jun 22, 2024 · Bellatrix Exploration Ltd., an oil and gas company, engages in the acquisition, exploration, development, and production of oil and natural gas reserves in the provinces of Alberta, British Columbia, and Saskatchewan in Canada.
- 800-5th Avenue SW Suite 1920, CALGARY A0, T2P 3T6
- investor.relations@bxe.com
- (403) 266-8670
- 144
Jun 19, 2024 · Bellatrix Exploration Ltd (TSE:BXE – Get Free Report) (NYSE:BXE)’s stock price traded down 5% during mid-day trading on Monday . The company traded as low as C$0.37 and last traded at C$0.38. 81,610 shares were traded during trading, an increase of 7% from the average session volume of 76,027 shares.
Jun 2, 2024 · TORONTO, Oct. 2, 2019 /CNW/ - The following issues have been halted by IIROC:
4 days ago · Bellatrix Aerospace has raised a total funding of $11.3M over 3 rounds from 28 investors. Investors include IDFC, H4XLabs and 26 others. Their latest funding round was of $8M on Jun 01, 2022 .
People also ask
What is Bellatrix Exploration Ltd (BXE-T)?
Should you buy or sell Bellatrix Exploration Ltd (BTX) stock?
Who owns Bellatrix Exploration Ltd?
6 days ago · Bellatrix Aerospace - Developer of in-space propulsion systems and orbital launch vehicles. Raised a total funding of $11.3M over 3 rounds from 28 investors. Valued at $35M.
